Browse
Explore conditions, clinical trials, and the organisations running them.
Never miss a new study
Get alerted when new trials match your condition
Sign up free to track the conditions you care about and get a personal digest when new trials appear.
By submitting, you agree to our Terms of use
127005 trials found · Page 3208 of 6351
-
New combo therapy shows promise for stroke hand recovery
Disease control CompletedResearchers at the University of Pittsburgh are conducting a research study to see how combining brain, nerve, and hand stimulation affect hand movement after stroke. The primary purpose of this study is to examine changes in the connection between the brain and the weak hand mus…
Sponsor: University of Utah • Aim: Disease control
Last updated Jun 27, 2026 12:37 UTC
-
Home workouts before transplant may boost strength in myeloma patients
Symptom relief Recruiting nowThe goal of this research study is to investigate whether a virtual, home-based, prehabilitation aerobic and resistance exercise (PARE) training program implemented 8 weeks prior to receiving autologous stem cell transplant (ASCT) for multiple myeloma participants will improve mu…
Sponsor: Dana-Farber Cancer Institute • Aim: Symptom relief
Last updated Jun 27, 2026 08:12 UTC
-
Smartphone sensors and apps could revolutionize monitoring of rare muscle diseases
Knowledge-focused CompletedThe low prevalence of rare diseases hinders the design of clinical studies with sufficient statistical power to demonstrate the efficacy of new drugs. This can only be achieved by setting up international multicentre studies, which is challenging due to a lack of objective, unive…
Sponsor: Institut de Myologie, France • Aim: Knowledge-focused
Last updated Jul 01, 2026 00:00 UTC
-
Veterans get fit at home: new study tests Tele-Rehab after COVID
Symptom relief Recruiting nowThe Coronavirus Disease 2019 (COVID-19) pandemic has resulted in catastrophic infections and fatalities across the nation. Many older Veterans with comorbidities are especially vulnerable to complications and poor recovery. This award will investigate the effect of a novel, home-…
Sponsor: VA Office of Research and Development • Aim: Symptom relief
Last updated Jun 27, 2026 07:56 UTC
-
Virus therapy fails to advance in colorectal cancer trial
Disease control Stopped earlyThis is an open-label, Phase 2 clinical trial evaluating therapy with an oncolytic immunotherapy (RP2 or RP3) in combination with atezolizumab and bevacizumab in patients with advanced Microsatellite Stable and Mismatch Repair Proficient Colorectal Carcinoma.
Phase 2 • Sponsor: Replimune, Inc. • Aim: Disease control
Last updated Jun 27, 2026 09:01 UTC
-
Experimental combo therapy for advanced cancer shows promise but trial ends early
Disease control Stopped earlyPhase 2, open-label, multicenter, randomized study comparing the safety and efficacy of personalized ultra-fractionated stereotactic adaptive radiotherapy (PULSAR) combined with immune checkpoint inhibitor (ICI) immunotherapy (PULSAR-ICI) + IMSA101 and PULSAR-ICI alone in patient…
Phase 2 • Sponsor: ImmuneSensor Therapeutics Inc. • Aim: Disease control
Last updated Jun 27, 2026 07:55 UTC
-
Spinal stimulation may boost arm recovery in new injury patients
Symptom relief Recruiting nowIn the United Kingdom, there are more than 1000 new cases of spinal cord injury (SCI) each year, with around half of these injuries affecting the cervical spine. People who have reduced function and control affecting their upper limbs may have difficulty carrying out activities o…
Sponsor: University College, London • Aim: Symptom relief
Last updated Jun 27, 2026 08:03 UTC
-
Smart dosing of blood thinner could save kidneys in children
Disease control CompletedAllograft vascular thrombosis is a devastating complication in kidney transplantation in adults and older children. Though uncommon, it is often irreversible and represents the main cause of graft loss within after kidney transplantation in adults and in the first post-operative …
Phase 4 • Sponsor: Assistance Publique - Hôpitaux de Paris • Aim: Disease control
Last updated Jul 09, 2026 00:00 UTC
-
Sugar showdown: could cutting sweets curb CF diabetes?
Knowledge-focused Recruiting nowThe goal of this study is to determine the extent to which excess dietary sugars serve as a precipitating factor in glucose intolerance in adults with cystic fibrosis (CF), a population at especially high risk for a unique form of diabetes (CF-related diabetes, CFRD) and with sta…
Sponsor: Emory University • Aim: Knowledge-focused
Last updated Jun 27, 2026 13:01 UTC
-
New knee implant study aims to help arthritis sufferers walk Pain-Free
Disease control OngoingThe main objective of the study is to evaluate the safety, performance and clinical benefits of the Persona implant and its instrumentation in primary total knee arthroplasty
Sponsor: Zimmer Biomet • Aim: Disease control
Last updated Jul 12, 2026 00:00 UTC
-
Can ultrasound replace CT scans after skull surgery?
Diagnosis Recruiting nowTranscranial Ultrasound via Sonolucent Cranioplasty is a prospective, single arm, observational, open label (non-blinded) study to collect real world evidence on the use of transcranial ultrasound via sonolucent cranioplasty.
Sponsor: Northwell Health • Aim: Diagnosis
Last updated Jun 26, 2026 17:06 UTC
-
Shingles vaccine safe and effective for HIV patients, study finds
Disease control CompletedThe purpose of this study is to compare the immunogenicity and safety of recombinant zoster vaccine according to CD4+ T-cell count and age in people living with HIV, and to provide evidence to guide immunization of people living with HIV.
Phase 4 • Sponsor: Seoul National University Hospital • Aim: Disease control
Last updated Jun 27, 2026 12:24 UTC
-
New pill could shrink uterine cancer without surgery
Disease control OngoingThis Phase II, global, single-arm study is designed to evaluate the efficacy, safety, and pharmacokinetics of giredestrant monotherapy in participants with Grade 1 endometrioid endometrial cancer.
Phase 2 • Sponsor: Hoffmann-La Roche • Aim: Disease control
Last updated Jul 12, 2026 00:00 UTC
-
New hope for advanced cancer patients? early trial begins
Disease control OngoingThis is an open-label phase 1 study with expansion. The study will start with a dose escalation of single-agent ABSK121-NX administered in repeated 28-day cycles in patients with advanced solid tumors to evaluate safety and tolerability. The expansion part will investigate oral A…
Phase 1 • Sponsor: Abbisko Therapeutics Co, Ltd • Aim: Disease control
Last updated Jun 27, 2026 07:55 UTC
-
Could a Vitamin-Like supplement ward off Alzheimer's in High-Risk individuals?
Disease control CompletedThe purpose of this study is to test the safety, tolerability, and effects of choline in people with increased risk of Alzheimer's Disease (AD), also known as pre-symptomatic AD. Choline is a dietary supplement, but is being investigated to see if it has any effects on the progre…
Phase 1 • Sponsor: Paul E Schulz • Aim: Disease control
Last updated Jun 27, 2026 12:23 UTC
-
Barbershops join fight against heavy drinking in rural men
Knowledge-focused OngoingUnhealthy drinking is considered one of the top 10 public health concerns in the United States. Not only has heavy drinking been linked to poorer overall health and the chances of getting cancer and cardiovascular diseases, but it also causes about 88,000 deaths and 2.5 million y…
Sponsor: University of Arkansas • Aim: Knowledge-focused
Last updated Jun 27, 2026 11:01 UTC
-
Can a tablet app ease dialysis symptoms? large trial launches
Symptom relief Recruiting nowThe SMaRRT-HD trial is a cluster randomized trial of symptom monitoring with supported clinician follow-up using the SMaRRT-HD electronic patient reported outcome measure (ePROM) system versus Usual Care. Approximately 2400 patients at up to 36 geographically and racially diverse…
Sponsor: University of Pennsylvania • Aim: Symptom relief
Last updated Jun 27, 2026 07:59 UTC
-
New drug shows promise for Post-Surgery sugar crashes
Disease control CompletedThis is a phase 2 crossover, randomized, placebo-controlled, single-blind, repeat dose study in PBH subjects to determine the effect of mizagliflozin on adverse events and postprandial glucose excursions.
Phase 2 • Sponsor: Vogenx, Inc. • Aim: Disease control
Last updated Jun 27, 2026 08:05 UTC
-
Can a simple writing therapy help veterans battle both PTSD and addiction?
Symptom relief CompletedPosttraumatic Stress Disorder (PTSD) and Substance Use Disorder (SUD) are highly comorbid, and comorbidity increases risk for poor functional outcomes. Risks for poor quality of life and suicide increase further for those with co-occurring PTSD and SUD diagnoses as compared to ei…
Sponsor: VA Office of Research and Development • Aim: Symptom relief
Last updated Jun 27, 2026 09:03 UTC
-
Virtual reality may protect young brains during cancer treatment
Symptom relief Recruiting nowThe objective of this study is to estimate the feasibility and acceptability of cognitive training in the virtual reality setting with children undergoing radiotherapy for brain tumors. To achieve this goal, the investigators plan to study children undergoing radiotherapy for bra…
Sponsor: St. Jude Children's Research Hospital • Aim: Symptom relief
Last updated Jun 27, 2026 14:00 UTC